Design, synthesis, and biological evaluation of piperazine derivatives involved in the 5-HT_1AR/BDNF/PKA pathway

References

• Gerhard DM, Duman RS. Rapid⁃acting antidepressants: mechanistic insights and future directions. Curr Behav Neurosci Rep. 2018;5(1):36–47. ⁃
   PubMedGoogle Scholar
• Meng P, Li C, Duan S, Ji S, Xu Y, Mao Y, Wang H, Tian J. Epigenetic mechanism of 5-HT/NE/DA triple reuptake inhibitor on adult depression susceptibility in early stress mice. Front Pharmacol. 2022;13:848251.
   PubMed Web of Science ®Google Scholar
• Garcia CS, Besckow EW, da Silva Espíndola CN, Avila Nunes GD, Zuge NP, de Azeredo MP, Rocha MJD, Carraro Junior LR, Penteado F, Gomes CS, et al. Antidepressant-like effect of a selenoindolizine in mice: in vivo and in silico evidence for the involvement of the serotonergic 5-HT2A/C receptors. ACS Chem Neurosci. 2022;13(12):1746–1755.
   PubMed Web of Science ®Google Scholar
• Sumalatha S, Venkataramaiah C, Naga RC. Design, synthesis, in vitro and in silico bioactivity profiles of new urea/thiourea derivatives of 2-pyridyl piperazine as potent antioxidant and antimicrobial agents: chemo-bio-computational approach. J Biomol Struct Dyn. 2023;41(10):4786–4797.
   PubMed Web of Science ®Google Scholar
• Wang A, Du N, Song HJ, Zhang YH, Zhong XJ, Wu JZ, Xue TZ, Liu ML, Wang B, Lv K, et al. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety. Eur J Med Chem. 2023;258:115545.
   PubMed Web of Science ®Google Scholar
• Sahu B, Bhatia R, Kaur D, Choudhary D, Rawat R, Sharma S, Kumar B. Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents. Bioorg Chem. 2023;136:106544.
   PubMed Web of Science ®Google Scholar
• Shaban RM, Samir N, Nissan YM, Abouzid KAM. Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4-d]pyrimidine derivatives as anti-cancer agents. RSC Adv. 2023;13(25):17074–17096.
   PubMed Web of Science ®Google Scholar
• Ansari SB, Kamboj S, Ramalingam K, Meena R, Lal J, Kant R, Shukla SK, Goyal N, Reddy DN. Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents. Bioorg Chem. 2023;137:106593.
   PubMed Web of Science ®Google Scholar
• Bose P, Agrahari AK, Singh R, Singh M, Kumar S, Singh RK, Tiwari VK. Click inspired synthesis of piperazine-triazolyl sugar-conjugates as potent anti-Hela activity. Carbohydr Res. 2023;529:108846.
   PubMed Web of Science ®Google Scholar
• Hua Y, Song MX, Guo QY, Luo YQ, Deng XQ, Huang YS. Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones. Molecules. 2023;28(8):3408.
   PubMed Web of Science ®Google Scholar
• Han ZF, Qi G, Zhu JK, Zhang YD, Xu Y, Yan K, Zhu CJ, Hao X. Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation. Bioorg Chem. 2020;105:104428.
   PubMed Web of Science ®Google Scholar
• Wang SB, Liu H, Wang XK, Lei K, Li GY, Li J, Liu RM, Quan ZS. Synthesis of 1,3,4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABAA receptor. Eur J Med Chem. 2020;206:112672.
   PubMed Web of Science ®Google Scholar
• Deng XQ, Song MX, Zheng Y, Quan ZS. Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones. Eur J Med Chem. 2014;73:217–224.
   PubMed Web of Science ®Google Scholar
• Wang S, Qi L, Liu H, Lei K, Wang X, Liu R. Design, Synthesis, and In Vivo and In Silico Evaluation of Coumarin Derivatives with Potential Antidepressant Effects. RSC Adv. 2020;10(51):30848–30857.
   PubMedGoogle Scholar
• Cao Y, Li Q. The variation of the 5-hydroxytryptamine system between chronic unpredictable mild stress rats and chronic fatigue syndrome rats induced by forced treadmill running. Neuroreport. 2017;28(11):630–637.
   PubMed Web of Science ®Google Scholar
• Blier P, Ward NM. Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiat. 2003;53:93–103.
   PubMed Web of Science ®Google Scholar
• Meyer JH, McMain S, Kennedy SH, Korman L, Brown GM, DaSilva JN, Wilson AA, Blak T, Eynan-Harvey R, Goulding VS, et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry. 2003;160(1):90–99.
   PubMed Web of Science ®Google Scholar
• Mikoteit T, Hemmeter U, Eckert A, Brand S, Bischof R, Delini-Stula A, Holsboer-Trachsler E, Beck J. Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression. Neuropsychobiology. 2015;72(1):16–28.
   PubMed Web of Science ®Google Scholar
• An JJ, Kinney CE, Tan JW, Liao GY, Kremer EJ, Xu B. TrkB-expressing paraventricular hypothalamic neurons suppress appetite through multiple neurocircuits. Nat Commun. 2020;11(1):1729.
   PubMed Web of Science ®Google Scholar
• Xu PY, Huang SJ, Zhang HB, Mao CY, Zhou XE, Cheng X, Simon IA, Shen DD, Yen HY, Robinson CV, et al. Structural insights into the lipid and ligand regulation of serotonin receptors. Nature. 2021;592(7854):469–473.
   PubMed Web of Science ®Google Scholar
• Sherin DR, Geethu CK, Prabhakaran J, Mann JJ, Dileep JS, Manojkumar TK. Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR agonists. Comput Biol Chem. 2019;78:108–115.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229(2):327–336.
   PubMedGoogle Scholar
• Stéru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl)). 1985;85(3):367–370.
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Verma P, Palit G. Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice. Indian J Exp Biol. 2010;48(3):306–313.
   PubMed Web of Science ®Google Scholar
• Elliott PJ, Chan J, Parker YM, Nemeroff CB. Behavioral effects of neurotensin in the open field: structure-activity studies. Brain Res. 1986;381(2):259–265.
   PubMed Web of Science ®Google Scholar
• Wang SB, Liu H, Li GY, Li J, Li XJ, Lei K, Wei LC, Quan ZS, Wang XK, Liu RM. Coumarin and 3,4-dihydroquinolinone derivatives: Synthesis, antidepressant activity, and molecular docking studies. Pharmacol Rep. 2019;71(6):1244–1252.
   PubMed Web of Science ®Google Scholar
• Gu ZS, Xiao Y, Zhang QW, Li JQ. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT1A/5-HT7. Bioorg Med Chem Lett. 2017;27(24):5420–5423.
   PubMed Web of Science ®Google Scholar
• He LW, Zeng L, Tian N, Li Y, He T, Tan DM, Zhang Q, Tan Y. Optimization of food deprivation and sucrose preference test in SD rat model undergoing chronic unpredictable mild stress. Animal Model Exp Med. 2020;3(1):69–78.
   PubMedGoogle Scholar
• Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl)). 1987;93(3):358–364.
   PubMed Web of Science ®Google Scholar
• Sun XN, Li N, Zhong PS, Chen L, Sun JB. Development of MAO‑A and 5‑HT2AR dual inhibitors with improved antidepressant activity. J Med Chem. 2022;65(19):13385–13400.
   PubMed Web of Science ®Google Scholar
• Wang JM, Chen RX, Liu C, Wu XH, Zhang YY. Antidepressant mechanism of catalpol: Involvement of the PI3K/Akt/Nrf2/HO-1 signaling pathway in rat hippocampus. Eur J Pharmacol. 2021;909:174396.
   PubMed Web of Science ®Google Scholar